血管紧张素转化酶抑制剂(ACEI)于八十年代初期在我国始用于治疗高血压和心力衰竭,目前该类药物有卡托普利、依那普利、培哚普利等,随着临床应用和研究深入渐发现该类药物对内科多种疾病有治疗作用,且疗效较好。现将其部分临床新用途介绍如下: 一、肝脏疾病 黄崇军报道42例顽固性肝硬化腹水病人在原治疗方案基础上,于腹腔内注射多巴胺20mg,每日一次,同时给予疏甲丙脯酸 Angiotensin converting enzyme inhibitors (ACEI) in the early eighties in China began to treat hypertension and heart failure, the current drugs such as captopril, enalapril, perindopril, etc., with the Clinical application and research in-depth discovery of these drugs have a therapeutic effect on a variety of medical diseases, and the effect is better. Now some of its clinical new uses are described below: First, liver disease Huang Chongjun reported 42 patients with refractory cirrhosis and ascites patients in the original treatment program based on the intraperitoneal injection of dopamine 20mg once daily while giving captopril